Assessing early changes in plasma HER2 levels is useful for predicting therapeutic response in advanced breast cancer: A multicenter, prospective, noninterventional clinical study
Kang, Yi‐Kun, Si, Yi‐Ran, Ju, Jie, Jia, Zhu‐Qing, Hu, Nan‐Lin, Dong, Hao, Wang, Xue, Yue, Jian, Jiang, Pei‐Di, Li, Zhao‐Liang, Zhang, Yun‐Yun, Wang, Yan, Xu, Bing‐He, Yuan, Peng
Published in Cancer medicine (Malden, MA) (01.03.2023)
Published in Cancer medicine (Malden, MA) (01.03.2023)
Get full text
Journal Article
The Effects of Endocrine Therapies on Lipid Profiles in Chinese Young Women With Early Breast Cancer
Kang, Yi-Kun, Wang, Xue, Hu, Nan-Lin, Yue, Jian, Si, Yi-Ran, Ju, Jie, Gao, Song-Lin, Yuan, Peng
Published in Frontiers in oncology (01.12.2021)
Published in Frontiers in oncology (01.12.2021)
Get full text
Journal Article
Impact of coronavirus disease 2019 on the clinical diagnosis and treatment of breast cancer in China
Si, Yi-Ran, Du, Feng, Hu, Nan-Lin, Wang, Xue, Yue, Jian, Jiang, Pei-Di, Xu, Bing-He, Yuan, Peng
Published in Chinese medical journal (05.03.2021)
Published in Chinese medical journal (05.03.2021)
Get full text
Journal Article
Combined analysis of receptor expression reflects inter-and intra-tumor heterogeneity in HR+/HER2+ breast cancer
Ju, Jie, Du, Feng, Gao, Song-Lin, Si, Yi-Ran, Hu, Nan-Lin, Liu, Dong-Xu, Wang, Xue, Yue, Jian, Zheng, Fang-Chao, Kang, Yi-Kun, Yang, Zi-Xuan, Ma, Fei, Xu, Bing-He, Yuan, Peng
Published in Breast cancer research and treatment (01.07.2022)
Published in Breast cancer research and treatment (01.07.2022)
Get full text
Journal Article